2021
DOI: 10.1109/jtehm.2021.3066800
|View full text |Cite
|
Sign up to set email alerts
|

Detecting Effect of Levodopa in Parkinson’s Disease Patients Using Sustained Phonemes

Abstract: Background: Parkinson’s disease (PD) is a multi-symptom neurodegenerative disease generally managed with medications, of which levodopa is the most effective. Determining the dosage of levodopa requires regular meetings where motor function can be observed. Speech impairment is an early symptom in PD and has been proposed for early detection and monitoring of the disease. However, findings from previous research on the effect of levodopa on speech have not shown a consistent picture. Method: This study has inv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
16
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 18 publications
(17 citation statements)
references
References 51 publications
1
16
0
Order By: Relevance
“…Interestingly, probably the most effort has been put into the investigation of the short-term effect of levodopa on voice quality; however, the results remain inconclusive. Whereas some authors found jitter, shimmer, HNR, cepstral peak prominence or pitch breaks to be unresponsive to short-term dopaminergic stimulation 5 , 6 , 9 , others were pointing to a dopamine-related amelioration in phonatory parameters 13 , 15 , 17 . Cushnie-Sparrow et al 6 divided patients into two groups based on voice quality severity perceptually evaluated by three listeners and found that only PD patients with poor voice quality off-medication showed improvements in voice quality on-medication, while those with better voice quality did not.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Interestingly, probably the most effort has been put into the investigation of the short-term effect of levodopa on voice quality; however, the results remain inconclusive. Whereas some authors found jitter, shimmer, HNR, cepstral peak prominence or pitch breaks to be unresponsive to short-term dopaminergic stimulation 5 , 6 , 9 , others were pointing to a dopamine-related amelioration in phonatory parameters 13 , 15 , 17 . Cushnie-Sparrow et al 6 divided patients into two groups based on voice quality severity perceptually evaluated by three listeners and found that only PD patients with poor voice quality off-medication showed improvements in voice quality on-medication, while those with better voice quality did not.…”
Section: Discussionmentioning
confidence: 99%
“…Yet, the available evidence about the effect of levodopa on speech in PD is limited due to small sample sizes, heterogeneity of studied population, lack of concise and valid speech recording and analysis methodology, and lack of motor scores. After levodopa intake, improvements in voice quality 13 , 15 , 17 , loudness 11 , 19 , speaking rate 14 , speech dysfluency 12 , respiration 5 , 8 and overall speech intelligibility 8 have been reported, while other studies found no significant changes in voice quality 5 , 6 , 9 , loudness 5 , 10 , 18 , speaking rate 7 , 9 , 18 , vowel articulation 11 , 18 , consonant articulation 20 , monopitch 5 , 9 , 18 or respiration 9 , 16 . This inconsistency may be caused, at least partially, by different disease duration and motor severity of investigated PD patients.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Table 2 provides the demographics of the subjects. The detailed information can be found in 22 , 32 .…”
Section: Methodsmentioning
confidence: 99%
“…Most of the studies were focused on the parameters that are closely related to impairments in vocal cord vibration. The pitch frequency variation, number of pulses, jitter (perturbation of the glottal vibration period), shimmer (amplitude perturbation of glottal vibration), autocorrelation, and harmonics to noise ratio (HNR/NHR) were used in the authors previous work 22 , as well as in the work of Orozco-Arroyave 23 , Behroozi et al 24 , Tsanas and Little 25 , Ali et al 26 , Sakar et al 19 , and Rusz et al 6 .…”
Section: Introductionmentioning
confidence: 99%